Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Granuloma, Plasma Cell × brigatinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 4 Neuroma, Acoustic 1 Neurofibromatosis 2 1 NSCLC 1 Meningioma 1 Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1 Ependymoma 1 ALK-positive Advanced NSCLC 1 ALK+ Advanced NSCLC 1

Interventions

pazopanib 2 Ifosfamide 2 Doxorubicin 2 selinexor 1 repotrectinib 1 ceritinib 1 brigatinib 1 Suspensions 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Crizotinib 1 Capsules 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04925609 2025-12-05

Briga-PED

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting

LymphoidPlasma cell

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡